Info at: abdn.ac.uk/ace
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
@jimcatto.bsky.social; @bursturology.bsky.social @akoupparis.bsky.social
www.linkedin.com/feed/update/...
www.linkedin.com/feed/update/...
Heer Lab, Vishwanath Hanchanale, Krishna Narahari
@benchallacombe.bsky.social @jimcatto.bsky.social @bursturology.bsky.social
Heer Lab, Vishwanath Hanchanale, Krishna Narahari
@benchallacombe.bsky.social @jimcatto.bsky.social @bursturology.bsky.social
@nihr.bsky.social
funded EVEREST Trial is officially a go 🚦 1st Green Light issued. Here’s to scaling new heights in Takotsubo research. #EVERESTTrial #Takotsubo #CHaRTtrials
@nhsgrampian.bsky.social @dana_dawson16
@nihr.bsky.social
funded EVEREST Trial is officially a go 🚦 1st Green Light issued. Here’s to scaling new heights in Takotsubo research. #EVERESTTrial #Takotsubo #CHaRTtrials
@nhsgrampian.bsky.social @dana_dawson16
trialsjournal.biomedcentral.com/articles/10....
@ukcrc-ctu.org.uk @ecrin.bsky.social
trialsjournal.biomedcentral.com/articles/10....
@ukcrc-ctu.org.uk @ecrin.bsky.social
@streweek.bsky.social
and team: Journal Trials mandating the use of a tool called PRO EDI to address the gap in reporting and interpretation of equity information. More info here👉 abdn.io/1H4
@streweek.bsky.social
and team: Journal Trials mandating the use of a tool called PRO EDI to address the gap in reporting and interpretation of equity information. More info here👉 abdn.io/1H4
#MethodologyMonday #125
#MethodologyMonday #125
trialsjournal.biomedcentral.com/articles/10....
trialsjournal.biomedcentral.com/articles/10....
www.abdn.ac.uk/ace/events/2...
And … our own Jemma Hudson is the featured author 😊
@docfarrow.bsky.social
@marionkcampbell.bsky.social
Links to papers below 👇
And … our own Jemma Hudson is the featured author 😊
@docfarrow.bsky.social
@marionkcampbell.bsky.social
Links to papers below 👇
on 7 September. bit.ly/3Vqbwqq
on 7 September. bit.ly/3Vqbwqq
#MethodologyMonday #123
#MethodologyMonday #123